Phase Ia Trial of a Polynucleotide Anti-Tumor Immunization to Human Carcinoembryonic Antigen in Patients with Metastatic Colorectal Cancer. University of Alabama at Birmingham, Birmingham, Alabama
- 10 April 1996
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 7 (6) , 755-772
- https://doi.org/10.1089/hum.1996.7.6-755
Abstract
The only peer-reviewed journal focused on the rapidly moving field of 3D printing and related technologies, providing comprehensive coverage of academic research and industrial and commercial developments that have applications in medicine, education, food, and architecture.Keywords
This publication has 40 references indexed in Scilit:
- Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus VaccineJNCI Journal of the National Cancer Institute, 1992
- Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanomaCancer, 1992
- Possibilities for Active Immunotherapy of Human CancerCancer Investigation, 1992
- Carcinoembryonic antigen gene family: Molecular biology and clinical perspectivesJournal of Clinical Laboratory Analysis, 1991
- Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.Journal of Clinical Oncology, 1990
- Active-specific immunotherapy for melanoma.Journal of Clinical Oncology, 1990
- Non-specific cross-reacting antigen: Characterization of specific and cross-reacting epitopesMolecular Immunology, 1989
- Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor-associated antigens (TAA). A phase I clinical trialCancer, 1985
- Prospectively randomized trial of adjuvant active‐specific immunotherapy for human colorectal cancerCancer, 1985
- Cea-related antigens: Molecular biology and clinical significanceCritical Reviews in Oncology/Hematology, 1985